Hypertension Trial, Recruiting NCT06511479 Sponsor: NYU Langone Health Condition: Hypertension
Back to Hypertension

Hypertension Trial, Recruiting

NCT06511479
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are female and already enrolled in the Jackson Heart Study
  • People who are willing to be randomly assigned to a study group and follow all parts of the study plan
  • People who are willing to have their group sessions audio-recorded

Who may not be able to join:

  • People who score below 19 on a standard memory and thinking test (called the MMSE), which may suggest cognitive difficulties
  • People who score 16 or higher on a standard depression symptom questionnaire (called the CES-D), indicating severe depressive symptoms
  • People who are currently pregnant or planning to become pregnant within the next 6 months
  • People who are currently taking part in another clinical trial
  • People whose upper arm measurement is larger than 45 cm or smaller than 22 cm

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Tanya Spruill, PhD, NYU Langone Health

Phone: 646-923-0626

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
18 November 2024
Est. completion
30 May 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in Systolic Blood Pressure

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov